These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8636321)

  • 1. Cortisol as mineralocorticoid.
    Ulick S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1307-8. PubMed ID: 8636321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension and steroid hormones].
    Miyamori I
    Nihon Rinsho; 1997 Aug; 55(8):1977-81. PubMed ID: 9284410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [11 beta-hydroxysteroid dehydrogenases: key enzymes in the action of mineralocorticoids and glucocorticoids].
    Diederich S; Quinkler M; Hanke B; Bähr V; Oelkers W
    Dtsch Med Wochenschr; 1999 Jan; 124(3):51-5. PubMed ID: 9987486
    [No Abstract]   [Full Text] [Related]  

  • 5. When is cortisol a mineralocorticoid?
    Clore J; Schoolwerth A; Watlington CO
    Kidney Int; 1992 Dec; 42(6):1297-308. PubMed ID: 1474763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol as a mineralocorticoid in human disease.
    Stewart PM
    J Steroid Biochem Mol Biol; 1999; 69(1-6):403-8. PubMed ID: 10419018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTH, cortisol and 11 beta-OHSD: quis custodet custodes?
    Funder J
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):481-2. PubMed ID: 1337503
    [No Abstract]   [Full Text] [Related]  

  • 9. Cortisol and hypertension: what was not so apparent about "apparent mineralocorticoid excess".
    Edwards C; Walker B
    J Lab Clin Med; 1993 Dec; 122(6):632-5. PubMed ID: 8245680
    [No Abstract]   [Full Text] [Related]  

  • 10. Developments in the molecular biology of corticosteroid synthesis and action: implications for an understanding of essential hypertension.
    Jamieson A; Fraser R
    J Hypertens; 1994 May; 12(5):503-9. PubMed ID: 7930549
    [No Abstract]   [Full Text] [Related]  

  • 11. Liquorice, growth retardation and Addison's disease.
    Doeker BM; Andler W
    Horm Res; 1999; 52(5):253-5. PubMed ID: 10844416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adrenal cortex: physiological function and disease.
    Nelson DH
    Major Probl Intern Med; 1980; 18():iii-xii, 1-281. PubMed ID: 6243382
    [No Abstract]   [Full Text] [Related]  

  • 13. The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess.
    Obeyesekere VR; Ferrari P; Andrews RK; Wilson RC; New MI; Funder JW; Krozowski ZS
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3381-3. PubMed ID: 7593456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: evidence for nuclear localization.
    Shimojo M; Ricketts ML; Petrelli MD; Moradi P; Johnson GD; Bradwell AR; Hewison M; Howie AJ; Stewart PM
    Endocrinology; 1997 Mar; 138(3):1305-11. PubMed ID: 9048640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function.
    Vinson GP
    J Endocrinol; 2011 Oct; 211(1):3-16. PubMed ID: 21715433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prismatic case of apparent mineralocorticoid excess.
    New MI
    J Clin Endocrinol Metab; 1994 Jul; 79(1):1-3. PubMed ID: 8027212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues.
    Rashid S; Lewis GF
    Clin Biochem; 2005 May; 38(5):401-9. PubMed ID: 15820768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.
    Funder JW; Pearce PT; Smith R; Campbell J
    Endocrinology; 1989 Oct; 125(4):2224-6. PubMed ID: 2551643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adrenal cortex and hypertension: some observations on a possible role for mineralocorticoids other than aldosterone.
    Fraser R; Brown JJ; Brown WC; Ferriss JB; Kennedy A; Lever AF; Mason PA; Morton JJ; Nicholls MG; Ramsay LE; Robertson JI; Schalekamp MA; Wilson A
    J Steroid Biochem; 1976; 7(11-12):963-70. PubMed ID: 192947
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing's disease of the kidney.
    Lancet; 1988 Oct; 2(8618):1002. PubMed ID: 2902435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.